Atorvastatin decreases proliferation of breast cancer cells more potently than rosuvastatin. by Colin H. Beckwitt (2037196)

Subjects:

Study flowchart. by Jaeseong Oh (3947381)

Subjects:

Comparison of PK parameters between genotype groups. by Jaeseong Oh (3947381)

Subjects:

Pharmacokinetic characteristics of oseltamivir in CES1 c.662A>G and wild-type subjects. by Jaeseong Oh (3947381)

Subjects:

Mean plasma concentration profiles of oseltamivir and oseltamivir carboxylate after a single oral administration of oseltamivir at 75 mg. by Jaeseong Oh (3947381)

Subjects:

ALS Variants of Annexin A11’s Proline-Rich Domain Impair Its S100A6-Mediated Fibril Dissolution by Aman Shihora (16529668)

Subjects:

HoxA9 binds three sites within the <i>Cebpa</i> +8 kb enhancer. by Lei Peng (260321)

Subjects:

HoxA9 represses and C/EBPα activates the <i>Cebpa</i> +8 kb enhancer in immature myeloid cells. by Lei Peng (260321)

Subjects:

HoxA9-ER directly represses <i>Cebpa</i> gene expression in myeloid cells. by Lei Peng (260321)

Subjects:

Expression of a <i>Cebpa</i> +37 kb enhancer/promoter transgene is reduced in hematopoietic progenitors with increased HoxA9. by Lei Peng (260321)

Subjects:

The <i>Cebpa</i> +8 kb enhancer is primed in HoxA9/Meis1-immortalized myeloid progenitors. by Lei Peng (260321)

Subjects:

C/EBPα binds five sites within the <i>Cebpa</i> +8 kb enhancer. by Lei Peng (260321)

Subjects:

Reciprocal relation between <i>HoxA9</i> and <i>Cebpa</i> in hematopoietic progenitors. by Lei Peng (260321)

Subjects:

Binding of HoxA9 and C/EBPα within the <i>Cebpa</i> locus. by Lei Peng (260321)

Subjects:

Transcriptomic analysis of the long-lived and short-lived Atg1 over-expressing flies reveals decreased lipid metabolism. by Ivana Bjedov (75652)

Elemental analysis shows a decreased N content in N stressed cells without a change in their C content. by Steve Dagenais Bellefeuille (654383)

Scenario analysis for pembrolizumab using a cumulative cost-based price per year per vial. by R. J. S. D. Heine (17889199)

Scenario analysis for daratumumab using a cumulative cost-based price per year per vial. by R. J. S. D. Heine (17889199)

Scatter plots with superimposed linear regression lines correlating logarithm of ADC with age in the basal ganglia. by Sylvain Eminian (5394746)

“…<p>a. Thalamus b. Caudate c. Putamen. There is a strong (R = -0.64 for Thalamus, R = -0.63 for Caudate, R = -0.65 for Putamen) and significant (with a p-value <10⁻⁴) decrease in ADC with respect to age.…”

Supplemental Figure 4. Lamp2a Silencing Decreased and Lamp2a Overexpression Increased Luciferase protein levels in CMA-reporter Expressing H9c2 cells. by Rajeshwary Ghosh (9764078)